Artículos por temáticas

Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity

Hill EJ, Mangleburg CG, Alfradique-Dunham I, Ripperger B, Stillwell A, Saade H, Rao S, Fagbongbe O, von Coelln R, Tarakad A, Hunter C, Dawe RJ, Jankovic J, Shulman LM, Buchman AS, Shulman JM.

Parkinsonism Relat Disord. 2021 Mar;84:105-111. doi: 10.1016/j.parkreldis.2021.02.006. Epub 2021 Feb 10.

Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus

Volonté MA, Clarizio G, Galantucci S, Scamarcia PG, Cardamone R, Barzaghi LR, Falautano M, Mortini P, Comi G, Filippi M.

J Neurol. 2021 Aug;268(8):2821-2830. doi: 10.1007/s00415-021-10430-y. Epub 2021 Feb 17.

Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters

Park DJ, Lee JW, Lee MJ, Ahn SJ, Kim J, Kim GL, Ra YJ, Cho YN, Jeong WB.

J Neural Transm (Vienna). 2021 Jan 28. doi: 10.1007/s00702-021-02301-7. Online ahead of print.

Regional Cerebral Cortical Atrophy is Related to Urinary Tract Symptoms in Parkinson's Disease

Roh H, Kang J, Hwang SY, Koh SB, Kim JH.

J Neuroimaging. 2021 Mar;31(2):363-371. doi: 10.1111/jon.12829. Epub 2021 Feb 3.

Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease

Sun BH, Wang T, Li NY, Wu Q, Qiao J.

World J Gastrointest Pharmacol Ther. 2021 Jan 5;12(1):21-31. doi: 10.4292/wjgpt.v12.i1.21.

Geospatial analysis of individual-based Parkinson's disease data supports a link with air pollution: A case-control study

Fleury V, Himsl R, Joost S, Nicastro N, Bereau M, Guessous I, Burkhard PR.

Parkinsonism Relat Disord. 2021 Jan 12;83:41-48. doi: 10.1016/j.parkreldis.2020.12.013. Online ahead of print.

Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study

Horisawa S, Fukui A, Yamahata H, Tanaka Y, Kuwano A, Momosaki O, Iijima M, Nanke M, Kawamata T, Taira T.

J Neurosurg. 2021 Jan 15:1-7. doi: 10.3171/2020.7.JNS201547. Online ahead of print.

Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study

Jørgensen LM, Henriksen T, Mardosiene S, Keller SH, Stenbæk DS, Hansen HD, Jespersen B, Thomsen C, Weikop P, Svarer C, Knudsen GM.

J Cereb Blood Flow Metab. 2021 Aug;41(8):1954-1963. doi: 10.1177/0271678X20982389. Epub 2021 Jan 18.

Single-Molecule Counting Coupled to Rapid Amplification Enables Detection of α-Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients

Bhumkar A, Magnan C, Lau D, Jun ESW, Dzamko N, Gambin Y, Sierecki E.

Angew Chem Int Ed Engl. 2021 May 17;60(21):11874-11883. doi: 10.1002/anie.202014898. Epub 2021 Apr 7.

Changes in corticomotor pathway excitability after exercise training in Parkinson's disease

Ginanneschi F, Messa LV, Battisti C, Rossi A.

Neurol Sci. 2021 Aug;42(8):3375-3381. doi: 10.1007/s10072-020-04960-y. Epub 2021 Jan 7.

Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities

Angelopoulou E, Nath Paudel Y, Piperi C, Mishra A.

J Biochem Mol Toxicol. 2021 Feb 15:e22711. doi: 10.1002/jbt.22711. Online ahead of print.

Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson's disease in rats: Possible role of endocannabinoid system modulation

Labib AY, Ammar RM, El-Naga RN, El-Bahy AAZ, Tadros MG, Michel HE.

Int Immunopharmacol. 2021 May;94:107431. doi: 10.1016/j.intimp.2021.107431. Epub 2021 Feb 9.

Therapeutic Potential of Magnetic Nanoparticle-Based Human Adipose-Derived Stem Cells in a Mouse Model of Parkinson's Disease

Kim KY, Chang KA.

Int J Mol Sci. 2021 Jan 11;22(2):654. doi: 10.3390/ijms22020654.

Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States

Thach A, Jones E, Pappert E, Pike J, Wright J, Gillespie A.

BMC Neurol. 2021 Jan 30;21(1):46. doi: 10.1186/s12883-021-02074-2.

Blood-brain barrier permeability in Parkinson's disease patients with and without dyskinesia

Fujita K, Peng S, Ma Y, Tang CC, Hellman M, Feigin A, Eidelberg D, Dhawan V.

J Neurol. 2021 Jun;268(6):2246-2255. doi: 10.1007/s00415-021-10411-1. Epub 2021 Jan 27.